APR 03, 2018 8:27 PM PDT

Two-Drug Strategy for Non-Small Cell Lung Cancer (NSCLC)

WRITTEN BY: Nouran Amin

According to the National Cancer Institute, lung cancer is the most common cause of cancer death for both men and women in the U.S. More specifically, non-small cell lung cancer (NSCLC) encompasses 85% of all lung cancers.

Investigators seeking new treatment options for patients of lung cancer have found a combination of drugs that are effective for NSCLC specifically. These drugs target epidermal growth factor receptor (EGFR) and tumor necrosis factor (TNF), the targeting works to effectively inhibit the cancer from using TNF as way to escape and allowing the cancer to be sensitive to the EGFR treatment.

"There has been a tremendous effort over the past several years to block EGFR as a treatment for lung cancer, but this therapy only works in a small subset of patients. The cancer fights back with a bypass pathway," explains lead researcher Dr. Amyn Habib with the Harold C. Simmons Comprehensive Cancer Center at UT Southwestern as well as a staff physician at the Dallas Veterans Affairs Medical Center. "Blocking both of these proteins could be a treatment that is beneficial for the majority of lung cancer patients.” These research findings stem from the same combination of drug treatments that were found to be successful in a glioblastoma mouse model.Bottom Rows: Tumors treated w/ two-drug strategy. Top Rows: Tumors left untreated or w/ a single treatment. Credit: UT Southwestern via Science Daily

Furthermore, these anti-EGFR/TNF two-strategy drugs were found to be well tolerated and with few side effects which was because they worked to target specific molecules within cancer cells. Thus, anti-EGFR/TNF drugs are more advantageous than traditional chemotherapeutic treatments which have unpleasant side-effects on a patient.

Investigators will continue their research for a phase 2 clinical trial of using the two-drug strategy; which has already been approved by the FDA. The prospective clinical studies are being planned to test the two-drug treatment in lung cancer patients as well as glioblastomas. "If this strategy is effective, then it might be broadly applicable not only against lung cancer but also against other cancers that express EGFR, which include brain, colon, and head and neck cancers," says lead clinical studies leader Dr. Gerber, an Associate Professor of Internal Medicine and Clinical Sciences.

Until recently, EGFR inhibitors were studied to be effective at treating a small percentage of non-small cell lung cancers that have a variant form of EGFR. However, with two-drug strategy, treatment could be effective for all forms of non-small cell lung cancers.

The research was published in the Journal of Clinical Investigation.

Source: Journal of Clinical Investigation, Science Daily

About the Author
  • Nouran is a scientist, educator, and life-long learner with a passion for making science more communicable. When not busy in the lab isolating blood macrophages, she enjoys writing on various STEM topics.
You May Also Like
MAY 03, 2021
Drug Discovery & Development
Low Dose Radiation May Improve Symptoms of Alzheimer's
MAY 03, 2021
Low Dose Radiation May Improve Symptoms of Alzheimer's
While high doses of radiation are known to be harmful, low doses may be able to help the body protect and repair. And no ...
JUN 02, 2021
Cannabis Sciences
Can CBD Help Manage Symptoms of Diabetes?
JUN 02, 2021
Can CBD Help Manage Symptoms of Diabetes?
As cannabidiol (CBD) products become increasingly mainstream, more people are using them to manage symptoms for chronic ...
JUN 14, 2021
Microbiology
Researchers Identify a Novel, Beneficial Bacterium
JUN 14, 2021
Researchers Identify a Novel, Beneficial Bacterium
Since researchers were able to use genetic technologies to reveal how important the gut microbiome is to human health, t ...
JUN 22, 2021
Neuroscience
Virtual Reality Game Provides Pain Relief for Children
JUN 22, 2021
Virtual Reality Game Provides Pain Relief for Children
Researchers led by Ohio State University have found that smartphone-based virtual reality (VR) games can relieve pain fr ...
JUL 05, 2021
Cannabis Sciences
Long Term CBD Use Linked to Less Pain, Anxiety and Depression
JUL 05, 2021
Long Term CBD Use Linked to Less Pain, Anxiety and Depression
Researchers from Canada have found that long-term use of cannabidiol (CBD) is linked to improved symptoms of pain, anxie ...
JUL 11, 2021
Drug Discovery & Development
Could Mucus-Based Drugs Replace Antibiotics?
JUL 11, 2021
Could Mucus-Based Drugs Replace Antibiotics?
Researchers from the Copenhagen Center for Glycomics in Denmark have developed a way to produce healthy mucus artificial ...
Loading Comments...